AI-generated summary
The authors studied 58 patients with rheumatoid arthritis who received low-energy helium-neon laser exposure and decimeter electromagnetic radiation of peripheral blood alongside standard drugs. They report changes in proliferation and apoptosis of mononuclear leucocytes, and that decimeter therapy was associated with clinical improvement by ACR criteria in a shorter time.
- Participants
- 58
- Who or what was studied
- Patients with rheumatoid arthritis of first and second degree of activity
- Limits stated in the abstract
- The abstract does not report control groups, sample size justification, or statistical details, and gives no measured effect sizes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.